targeted immune treatments

New T1D Immune Targeted Therapies on the Horizon By: Tiffany Richardson  Summary: Type 1 Diabetes (T1D) occurs after a targeted attack on insulin-producing beta cells…

Finding “genius” in T1D’s heterogeneous nature By: Hadeel Saab In the 1990s, the asthma field came to an important realization that there were multiple pathophysiological…

Nanoparticles: Flattening the Curve and Type 1 Diabetes By: James LeFevre Currently, a lot of ongoing research has focused on the COVID-19 pandemic in order…

Two birds, one stone By: James LeFevre Diabetes and hypertension are like a dynamic duo. Through numerous pathophysiological mechanisms, diabetes and hypertension are strongly linked.…

hold on a ‘seq’: rna for t1d biomarkers By: Hadeel Saab Biological research was taken to the next level with next-generation sequencing, a technology that…

Targeted Immune Treatments: New Areas of Interest  By: Mari Yamamoto Though they show some potential in alleviating the course of the disease, nonspecific therapies for…

Immunotherapies are used to treat various diseases by “boosting” the body’s immune system. Though an approach commonly used in cancer treatment, immunotherapy is also showing…

Bull’s-eye: Targeted Immune Treatments for Diabetes  T1D is an autoimmune disease where effector T cells (Teff) attack the islet cells that produce insulin. This autoreactivity…